Welcome to the Dignity study
The Dignity study is a phase III international multi-center study to determine the efficacy and safety of a new experimental medication for the control of urinary incontinence episodes, a symptom of an overactive bladder, in patients with spinal cord injury or multiple sclerosis.
If you suffer from an overactive bladder as a result of multiple sclerosis or a spinal cord injury and you have not been able to control the problem with existing treatments, please continue to navigate through this website to find out if you are eligible to participate in the Dignity study.
You can really make a difference by getting involved in research that could shape the future treatment of overactive bladder and urinary incontinence.
The Dignity study is sponsored by Allergan Inc and supports the company's focus on identifying and developing innovative products for meeting unmet or under-served patient needs through discovery research projects and collaboration with academic and clinical partners.
The protocol for the Dignity study has undergone the appropriate review by regulatory authorities and ethics committees.
Is an Overactive Bladder Causing You to Live an Underactive Life?
